hotspot -WSS

hotspot

author：leisure time 2025-09-27 10:04:47 - browse：37

Blue CAR-T cell attacks a leukemia cell. --health coverage from STAT — Engineered receptors on the surface of a T-lymphocyte bind to a leukemia cell. Adobe

The announcement on Tuesday that the Food and Drug Administration was investigating whether CAR-T immunotherapy had itself caused blood cancers initially appeared to be a significant blow to one of the brightest spots in cancer care.

But experts quickly cautioned that risk of this complication is probably minuscule compared to the known risk of secondary cancers from other cancer therapies like chemotherapy and radiation. They noted that CAR-T cells are immune cells that are genetically engineered to fight cancer, and that such genetic modifications were long thought to carry a risk of causing a second, new cancer in patients. The surprise, in a way, is that since CAR-T was first invented more than 10 years ago, that risk had remained just theoretical.

“There’s been a requirement for long-term follow up. I think this is why we’re all surprised. As far as I think any one of us knew, it’d never happened with any of the FDA-approved CAR-Ts,” said Marcela Maus, a cell therapy researcher at Mass General Cancer Center.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： George Santos makes 1st court appearance after pleading not guilty to 13 counts
Next article： Abortion policy in the spotlight at Republican debate

knowledge

WSS

Trans patients at the end of life deserve respect and dignity

Readout Newsletter: What happened with Sarepta's Duchenne data

Emergency medicine has repudiated 'excited delirium.' Now what?

Readout Newsletter: The latest from Bristol, Sarepta, and Novartis

First Opinion Podcast: How to protect health care in times of war

The FDA weighs the risks of candy

hotspot

hotspot

focus

United colonoscopy coverage change 'may cost lives,' doctors say

Testing for cancer recurrence creates a new limbo for patients

In age of alternative facts, a scholarly course on calling out crap

Trans patients at the end of life deserve respect and dignity

Medical leaders decry Supreme Court decision on affirmative action

Health officials lay out plans to cope with respiratory virus season

Hepatitis C has a cure — but many Americans still lack access to it

What past blockbusters can tell us about future of Wegovy and other weight loss medicines

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Medtronic CEO on promising devices for diabetes, hypertension

Wikipedia

Wegovy improves function in certain heart failure patients

Roche's accidental data boosts hopes for anti

As obesity drug market grows, telehealth companies court payers

Readout Newsletter: XBI biotech index, Akero Therapeutics

National associations that represent hospice owe an apology

FDA greenlights medical device to combat bladder issues

hotspot

knowledge

hotspot

focus